- Home
- GENC vs PRQR Comparison
GENC vs PRQR Comparison
Compare GENC & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GENC
- PRQR
- Stock Information
- Founded
- GENC 1894
- PRQR 2012
- Country
- GENC United States
- PRQR Netherlands
- Employees
- GENC 317
- PRQR N/A
- Industry
- GENC Construction/Ag Equipment/Trucks
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- GENC Industrials
- PRQR Health Care
- Exchange
- GENC Nasdaq
- PRQR Nasdaq
- Market Cap
- GENC 224.6M
- PRQR 309.5M
- IPO Year
- GENC N/A
- PRQR 2014
- Fundamental
- Price
- GENC $15.10
- PRQR $2.19
- Analyst Decision
- GENC
- PRQR Strong Buy
- Analyst Count
- GENC 0
- PRQR 5
- Target Price
- GENC N/A
- PRQR $7.60
- AVG Volume (30 Days)
- GENC 24.3K
- PRQR 363.5K
- Earning Date
- GENC 02-11-2025
- PRQR 03-12-2025
- Dividend Yield
- GENC N/A
- PRQR N/A
- EPS Growth
- GENC 35.02
- PRQR N/A
- EPS
- GENC 1.11
- PRQR N/A
- Revenue
- GENC $113,116,000.00
- PRQR $20,506,357.00
- Revenue This Year
- GENC N/A
- PRQR $210.30
- Revenue Next Year
- GENC N/A
- PRQR $39.89
- P/E Ratio
- GENC $13.37
- PRQR N/A
- Revenue Growth
- GENC 5.44
- PRQR 306.68
- 52 Week Low
- GENC $14.75
- PRQR $1.61
- 52 Week High
- GENC $24.88
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- GENC 30.47
- PRQR 42.45
- Support Level
- GENC $15.29
- PRQR $1.95
- Resistance Level
- GENC $16.33
- PRQR $2.46
- Average True Range (ATR)
- GENC 0.63
- PRQR 0.16
- MACD
- GENC 0.05
- PRQR 0.03
- Stochastic Oscillator
- GENC 0.00
- PRQR 53.31
About GENC Gencor Industries Inc.
Gencor Industries Inc and its subsidiaries is a manufacturer of heavy machinery used in the production of highway construction materials and environmental control equipment. The Company has one reporting segment, equipment for the highway construction industry. The firm's principal products include asphalt plants, combustion systems, hot mix asphalt plants, fluid heat transfer systems, and asphalt pavers.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.